Cell Reports (Feb 2024)

Partial loss of MCU mitigates pathology in vivo across a diverse range of neurodegenerative disease models

  • Madeleine J. Twyning,
  • Roberta Tufi,
  • Thomas P. Gleeson,
  • Kinga M. Kolodziej,
  • Susanna Campesan,
  • Ana Terriente-Felix,
  • Lewis Collins,
  • Federica De Lazzari,
  • Flaviano Giorgini,
  • Alexander J. Whitworth

Journal volume & issue
Vol. 43, no. 2
p. 113681

Abstract

Read online

Summary: Mitochondrial calcium (Ca2+) uptake augments metabolic processes and buffers cytosolic Ca2+ levels; however, excessive mitochondrial Ca2+ can cause cell death. Disrupted mitochondrial function and Ca2+ homeostasis are linked to numerous neurodegenerative diseases (NDs), but the impact of mitochondrial Ca2+ disruption is not well understood. Here, we show that Drosophila models of multiple NDs (Parkinson’s, Huntington’s, Alzheimer’s, and frontotemporal dementia) reveal a consistent increase in neuronal mitochondrial Ca2+ levels, as well as reduced mitochondrial Ca2+ buffering capacity, associated with increased mitochondria-endoplasmic reticulum contact sites (MERCs). Importantly, loss of the mitochondrial Ca2+ uptake channel MCU or overexpression of the efflux channel NCLX robustly suppresses key pathological phenotypes across these ND models. Thus, mitochondrial Ca2+ imbalance is a common feature of diverse NDs in vivo and is an important contributor to the disease pathogenesis. The broad beneficial effects from partial loss of MCU across these models presents a common, druggable target for therapeutic intervention.

Keywords